Satellos Bioscience's market cap is currently $116.36M. The company's EPS TTM is C$-0.041; its P/E ratio is ―; Satellos Bioscience is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is C$-0.04. See an overview of income statement, balance sheet, and cash flow financials.
